Global Biopharmaceutical Logistics 麻豆原创 Report 2018-2029

Publication ID:

HJR06230035

Publication Date:

June 29, 2023

Pages:

136

Publisher:

HJResearch

Countries:

Global [1]

USD 3,200.00

Medical Devices [2]

Pharmaceutical Manufacturing [3]

Pharma & Healthcare [4]

Description:

Biopharmaceutical Logistics is a specialty logistics service that provides the safe and reliable transportation and storage of biopharmaceutical products, such as vaccines, blood products, and other high-value, temperature-sensitive medications. The transportation of biopharmaceuticals requires strict adherence to temperature-controlled conditions, ensuring that the products reach their destination in optimal condition.

The global Biopharmaceutical Logistics market size in 2022 is expected to reach US$105900 million, with a compound annual growth rate of 7.9%. The growth of this industry is driven by several factors, including the increasing demand for biopharmaceuticals, advancements in technology that allow for more precise monitoring and control of temperature-sensitive products during transport, and the rising need for specialized cold chain logistics services.

Biopharmaceutical Logistics is mainly used for Cold Chain Logistics and Non-cold Chain Logistics. Cold chain logistics services involve transportation and storage of temperature-sensitive products, including refrigerated and frozen items, while non-cold chain logistics deal with products that do not require temperature-controlled environments during transportation.

The major global manufacturers in Biopharmaceutical Logistics include FedEx Corporation, Ceva Logistics, Amerisource Bergen Corporation, Panalpina Group, Kuehne + Nagel International, XPO Logistics, Inc, United Parcel Service, Deutsche Post DHL Group, DB Schenker, and C.H. Robinson Worldwide. These companies are investing heavily in research and development to improve their logistics capabilities, expand their market presence, and drive innovation in the industry.

The future prospects for Biopharmaceutical Logistics appear bright, given the continued growth in demand for biopharmaceuticals and the increasing need for specialized, temperature-controlled logistics services. However, the industry also faces challenges such as increasing competition from alternative logistics providers, the high cost of logistics services, and regulatory requirements that can lead to delays in product development and approval.

In conclusion, Biopharmaceutical Logistics is a specialized logistics service that provides reliable and safe transportation and storage of biopharmaceutical products. The global market for this industry is expected to grow at a compound annual growth rate of 7.9%, driven by several factors, including the increasing demand for biopharmaceuticals and advancements in technology that allow for more precise monitoring and control of temperature-sensitive products during transport. Major global manufacturers are investing in research and development to improve their logistics capabilities, expand their market presence, and drive innovation in the industry. However, the industry faces challenges such as increasing competition and regulatory requirements that can lead to delays in product development and approval.

The SWOT analysis of the Biopharmaceutical Logistics industry is as follows:

Strengths:
Biopharmaceutical Logistics is a highly specialized service that requires advanced technology and expertise, which limits the number of companies that can offer these services and creates barriers to entry for new players.
The increasing demand for biopharmaceutical products, including vaccines and other temperature-sensitive medications, is driving growth in the Biopharmaceutical Logistics industry.
Major global manufacturers in this industry are investing heavily in research and development to improve their logistics capabilities, expand their market presence, and drive innovation in the industry.

Weaknesses:
The high cost of Biopharmaceutical Logistics services can make them less accessible to certain patient populations, particularly in lower-income countries or those without adequate health insurance coverage.
The industry is highly regulated, with strict requirements for handling and transporting biopharmaceutical products, which can create compliance challenges for logistics providers.

Opportunities:
The increasing demand for biopharmaceutical products and the need for specialized, temperature-controlled logistics services present significant growth opportunities for companies in the Biopharmaceutical Logistics industry.
Advancements in technology, such as the use of artificial intelligence and blockchain, could potentially improve the accuracy, speed, and safety of Biopharmaceutical Logistics, driving increased adoption rates and market growth.
Emerging markets present an opportunity for Biopharmaceutical Logistics manufacturers to expand their market presence and increase sales in regions with high rates of diseases like cancer, diabetes, and heart disease that require biopharmaceuticals.

Threats:
Competition from alternative logistics providers, such as general cargo carriers or courier services, could limit the growth of the Biopharmaceutical Logistics industry.
Economic downturns and geopolitical instability could impact market growth in some regions, potentially limiting demand for Biopharmaceutical Logistics services.
Regulatory changes could impact the Biopharmaceutical Logistics industry, leading to increased compliance costs or decreased demand for certain types of logistics services.

Key players in global Biopharmaceutical Logistics market include:
FedEx Corporation
Ceva Logistics
Amerisource Bergen Corporation
Panalpina Group
Kuehne + Nagel International
XPO Logistics, Inc
United Parcel Service
Deutsche Post DHL Group
DB Schenker
C.H. Robinson Worldwide

麻豆原创 segmentation, by product types:
Air Shipping
Sea Shipping
Road Shipping
Rail Shipping

麻豆原创 segmentation, by applications:
Cold Chain Logistics
Non-cold Chain Logistics

Table Of Contents:

1 Industry Overview of Biopharmaceutical Logistics
1.1 Research Scope
1.2 麻豆原创 Segmentation by Types of Biopharmaceutical Logistics
1.3 麻豆原创 Segmentation by End Users of Biopharmaceutical Logistics
1.4 麻豆原创 Dynamics Analysis of Biopharmaceutical Logistics
1.4.1 麻豆原创 Drivers
1.4.2 麻豆原创 Challenges
1.4.3 麻豆原创 Opportunities
1.4.4 Porter鈥檚 Five Forces

2 Major Manufacturers Analysis of Biopharmaceutical Logistics Industry
2.1 FedEx Corporation
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Biopharmaceutical Logistics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Ceva Logistics
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Biopharmaceutical Logistics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Amerisource Bergen Corporation
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Biopharmaceutical Logistics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Panalpina Group
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Biopharmaceutical Logistics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Kuehne + Nagel International
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Biopharmaceutical Logistics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 XPO Logistics, Inc
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Biopharmaceutical Logistics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 United Parcel Service
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Biopharmaceutical Logistics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Deutsche Post DHL Group
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Biopharmaceutical Logistics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 DB Schenker
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Biopharmaceutical Logistics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 C.H. Robinson Worldwide
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 Biopharmaceutical Logistics Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.10.4 Contact Information

3 Global Biopharmaceutical Logistics 麻豆原创 Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Volume and Revenue of Biopharmaceutical Logistics by Regions (2018-2023)
3.2 Global Sales Volume and Revenue of Biopharmaceutical Logistics by Manufacturers (2018-2023)
3.3 Global Sales Volume and Revenue of Biopharmaceutical Logistics by Types (2018-2023)
3.4 Global Sales Volume and Revenue of Biopharmaceutical Logistics by End Users (2018-2023)
3.5 Selling Price Analysis of Biopharmaceutical Logistics by Regions, Manufacturers, Types and End Users in (2018-2023)

4 Northern America Biopharmaceutical Logistics 麻豆原创 Analysis by Countries, Types and End Users
4.1 Northern America Biopharmaceutical Logistics Sales Volume and Revenue Analysis by Countries (2018-2023)
4.2 Northern America Biopharmaceutical Logistics Sales Volume and Revenue Analysis by Types (2018-2023)
4.3 Northern America Biopharmaceutical Logistics Sales Volume and Revenue Analysis by End Users (2018-2023)
4.4 United States Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
4.5 Canada Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)

5 Europe Biopharmaceutical Logistics 麻豆原创 Analysis by Countries, Types and End Users
5.1 Europe Biopharmaceutical Logistics Sales Volume and Revenue Analysis by Countries (2018-2023)
5.2 Europe Biopharmaceutical Logistics Sales Volume and Revenue Analysis by Types (2018-2023)
5.3 Europe Biopharmaceutical Logistics Sales Volume and Revenue Analysis by End Users (2018-2023)
5.4 Germany Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.5 France Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.6 UK Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.7 Italy Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.8 Russia Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.9 Spain Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.10 Netherlands Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)

6 Asia Pacific Biopharmaceutical Logistics 麻豆原创 Analysis by Countries, Types and End Users
6.1 Asia Pacific Biopharmaceutical Logistics Sales Volume and Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Biopharmaceutical Logistics Sales Volume and Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Biopharmaceutical Logistics Sales Volume and Revenue Analysis by End Users (2018-2023)
6.4 China Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.5 Japan Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.6 Korea Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.7 India Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.8 Australia Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.9 Indonesia Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.10 Vietnam Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)

7 Latin America Biopharmaceutical Logistics 麻豆原创 Analysis by Countries, Types and End Users
7.1 Latin America Biopharmaceutical Logistics Sales Volume and Revenue Analysis by Countries (2018-2023)
7.2 Latin America Biopharmaceutical Logistics Sales Volume and Revenue Analysis by Types (2018-2023)
7.3 Latin America Biopharmaceutical Logistics Sales Volume and Revenue Analysis by End Users (2018-2023)
7.4 Brazil Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.5 Mexico Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.6 Argentina Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.7 Colombia Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)

8 Middle East & Africa Biopharmaceutical Logistics 麻豆原创 Analysis by Countries, Types and End Users
8.1 Middle East & Africa Biopharmaceutical Logistics Sales Volume and Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Biopharmaceutical Logistics Sales Volume and Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Biopharmaceutical Logistics Sales Volume and Revenue Analysis by End Users (2018-2023)
8.4 Turkey Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.5 Saudi Arabia Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.6 South Africa Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.7 Egypt Biopharmaceutical Logistics Sales Volume, Revenue, Import and Export Analysis (2018-2023)

9 麻豆原创ing Channel, Distributors and Traders Analysis
9.1 麻豆原创ing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders

10 Global Biopharmaceutical Logistics 麻豆原创 Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Volume and Revenue Forecast of Biopharmaceutical Logistics by Regions (2024-2029)
10.2 Global Sales Volume and Revenue Forecast of Biopharmaceutical Logistics by Types (2024-2029)
10.3 Global Sales Volume and Revenue Forecast of Biopharmaceutical Logistics by End Users (2024-2029)
10.4 Global Revenue Forecast of Biopharmaceutical Logistics by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)

11 Industry Chain Analysis of Biopharmaceutical Logistics
11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Biopharmaceutical Logistics
11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Biopharmaceutical Logistics
11.1.2 Major Equipment Suppliers with Contact Information Analysis of Biopharmaceutical Logistics
11.2 Downstream Major Consumers Analysis of Biopharmaceutical Logistics
11.3 Major Suppliers of Biopharmaceutical Logistics with Contact Information
11.4 Supply Chain Relationship Analysis of Biopharmaceutical Logistics

12 Biopharmaceutical Logistics New Project Investment Feasibility Analysis
12.1 Biopharmaceutical Logistics New Project SWOT Analysis
12.2 Biopharmaceutical Logistics New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule

13 Biopharmaceutical Logistics Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.